Filter
1594
Text search:
Américas
Featured
173
324
Language
Document type
562
435
239
100
94
51
31
29
26
10
5
5
3
2
1
Countries
244
135
44
26
25
22
18
14
13
12
12
10
9
9
8
8
8
7
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
329
179
135
112
77
26
18
1
Toolboxes
186
178
147
116
81
80
63
47
43
43
41
39
38
36
33
27
25
22
18
17
17
14
14
7
4
1
ATLAS on substance use (2010) — Resources for the prevention and treatment of substance use disorders
Accessed: 14.03.2019
ATLAS on substance use (2010) — Resources for the prevention and treatment of substance use disorders
Accessed: 14.03.2019
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
Assessing and improving quality and human rights in mental health and social care facilites
World Drug Report 2017
-5-
Accessed: 14.03.2019
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
World Drug Report 2017
-1-
Accessed: 14.03.2019
Perspectives sur les drogues
Perspectivas sobre las drogas
Perspectives on Drugs
Based on the survey, five principles for deinstitutionalization were identified: community-based services must be in place; the health workforce must be committed to change; political support at the highest and broadest levels is crucial; timing is key; and additional financial resources are needed.
...
Building laboratory testing capacity
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
SADF POLICY BRIEF
31 October 2018 Issue n° 8
ISSN: 2406-5625
